Skip to main content
Erschienen in: European Journal of Pediatrics 1/2021

28.07.2020 | Original Article

Predicting ambulatory function at skeletal maturity in children with moderate to severe osteogenesis imperfecta

verfasst von: Kathleen Montpetit, Marie-Elaine Lafrance, Francis H. Glorieux, François Fassier, Reggie Hamdy, Frank Rauch

Erschienen in: European Journal of Pediatrics | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Maximizing ambulation is a key treatment aim in moderate to severe osteogenesis imperfecta (OI). Here we investigated which early clinical characteristics predicted ambulation function at skeletal maturity. We assessed Bleck ambulation scores in 88 individuals with OI at 5 to 6 years of age and again at final height (at 15 to 24 years of age). At 5 to 6 years of age, 33 (38%) children were non-ambulators, 32 (36%) were fully independent ambulators, and 23 (26%) had intermediate ambulation skills. At skeletal maturity, 58% of the study participants had the same mobility level as at first assessment. The ability to ambulate independently at skeletal maturity was predicted by independent ambulation at 5 to 6 years (odds ratio [OR] 22.6, 95% confidence interval [CI] 4.9–105; P < 0.001), height z score at 5 to 6 years (OR 3.1, CI 1.6–6.3; P = 0.001) and weight z score at 5 to 6 years (OR 0.44, CI 0.19–0.99; P = 0.04).
Conclusion: Independent ambulation at 5 to 6 years was the main determinant of independent ambulation at skeletal maturity. This highlights the importance of maximizing ambulation in children below 5 years of age.
What is Known:
•walking ability varies markedly between OI types. The highest level of mobility was found in OI type I, the lowest in OI type III who require mobility aids; intermediate levels were reported for OI type IV.
• OI type is a key predictor of ultimate ability to ambulate, whereas the timing of developmental milestones was not associated with walking ability
What is New:
• overall key predictors of mobility function at skeletal maturity were mobility status and height z-score at 5-6 years of age
• Childrenwho were non-ambulators at 5 to 6 years of age had a higher chance of having better mobility at skeletal maturity if they had good upper extremity function, as expressed in the PEDI Self Care Score
Literatur
2.
Zurück zum Zitat Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, Nishimura G, Robertson S, Sangiorgi L, Savarirayan R, Sillence D, Superti-Furga A, Unger S, Warman ML (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 179:2393–2419. https://doi.org/10.1002/ajmg.a.61366CrossRefPubMed Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, Nishimura G, Robertson S, Sangiorgi L, Savarirayan R, Sillence D, Superti-Furga A, Unger S, Warman ML (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 179:2393–2419. https://​doi.​org/​10.​1002/​ajmg.​a.​61366CrossRefPubMed
6.
Zurück zum Zitat Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O (2018) Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis 13:158. https://doi.org/10.1186/s13023-018-0905-4CrossRefPubMedPubMedCentral Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O (2018) Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis 13:158. https://​doi.​org/​10.​1186/​s13023-018-0905-4CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150–2157. https://doi.org/10.1002/jbmr.2567CrossRefPubMed Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150–2157. https://​doi.​org/​10.​1002/​jbmr.​2567CrossRefPubMed
9.
Zurück zum Zitat Engelbert RH, Uiterwaal CS, Gulmans VA, Pruijs H, Helders PJ (2000) Osteogenesis imperfecta in childhood: prognosis for walking. J Pediatr 137:397–402CrossRef Engelbert RH, Uiterwaal CS, Gulmans VA, Pruijs H, Helders PJ (2000) Osteogenesis imperfecta in childhood: prognosis for walking. J Pediatr 137:397–402CrossRef
13.
Zurück zum Zitat Bleck EE (1981) Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management. Clin Orthop 111–122 Bleck EE (1981) Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management. Clin Orthop 111–122
14.
Zurück zum Zitat Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Anrellos PJ (1992) Pediatric Evaluation of Disability Inventory (PEDI): development, standardization and administrative manual. New England Medical Center, Boston Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Anrellos PJ (1992) Pediatric Evaluation of Disability Inventory (PEDI): development, standardization and administrative manual. New England Medical Center, Boston
16.
Zurück zum Zitat Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60CrossRef Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60CrossRef
18.
Zurück zum Zitat Jain M, Tam A, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Bellur S, Byers PH, Pepin M, Durigova M, Glorieux FH, Rauch F, Lee B, Sutton VR, Consortium MotBBD, Nagamani SCS (2019) Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med 21:275–283. https://doi.org/10.1038/s41436-018-0045-1CrossRefPubMed Jain M, Tam A, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Bellur S, Byers PH, Pepin M, Durigova M, Glorieux FH, Rauch F, Lee B, Sutton VR, Consortium MotBBD, Nagamani SCS (2019) Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med 21:275–283. https://​doi.​org/​10.​1038/​s41436-018-0045-1CrossRefPubMed
Metadaten
Titel
Predicting ambulatory function at skeletal maturity in children with moderate to severe osteogenesis imperfecta
verfasst von
Kathleen Montpetit
Marie-Elaine Lafrance
Francis H. Glorieux
François Fassier
Reggie Hamdy
Frank Rauch
Publikationsdatum
28.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 1/2021
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-020-03754-w

Weitere Artikel der Ausgabe 1/2021

European Journal of Pediatrics 1/2021 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.